Sirona Biochem Corp Stock Probability of Future Stock Price Finishing Under 0.11

SBM Stock  CAD 0.07  0.01  8.33%   
Sirona Biochem's future price is the expected price of Sirona Biochem instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sirona Biochem Corp performance during a given time horizon utilizing its historical volatility. Check out Sirona Biochem Backtesting, Sirona Biochem Valuation, Sirona Biochem Correlation, Sirona Biochem Hype Analysis, Sirona Biochem Volatility, Sirona Biochem History as well as Sirona Biochem Performance.
  
Please specify Sirona Biochem's target price for which you would like Sirona Biochem odds to be computed.

Sirona Biochem Target Price Odds to finish below 0.11

The tendency of Sirona Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under C$ 0.11  after 90 days
 0.07 90 days 0.11 
close to 99
Based on a normal probability distribution, the odds of Sirona Biochem to stay under C$ 0.11  after 90 days from now is close to 99 (This Sirona Biochem Corp probability density function shows the probability of Sirona Stock to fall within a particular range of prices over 90 days) . Probability of Sirona Biochem Corp price to stay between its current price of C$ 0.07  and C$ 0.11  at the end of the 90-day period is about 41.06 .
Assuming the 90 days horizon the stock has the beta coefficient of 3.61 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sirona Biochem will likely underperform. Moreover Sirona Biochem Corp has an alpha of 1.628, implying that it can generate a 1.63 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Sirona Biochem Price Density   
       Price  

Predictive Modules for Sirona Biochem

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sirona Biochem Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sirona Biochem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0515.98
Details
Intrinsic
Valuation
LowRealHigh
0.000.0515.98
Details

Sirona Biochem Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sirona Biochem is not an exception. The market had few large corrections towards the Sirona Biochem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sirona Biochem Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sirona Biochem within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.63
β
Beta against Dow Jones3.61
σ
Overall volatility
0.02
Ir
Information ratio 0.11

Sirona Biochem Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sirona Biochem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sirona Biochem Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sirona Biochem Corp is way too risky over 90 days horizon
Sirona Biochem Corp has some characteristics of a very speculative penny stock
Sirona Biochem Corp appears to be risky and price may revert if volatility continues
Sirona Biochem Corp has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Sirona Biochem Corp has accumulated 637.65 K in total debt with debt to equity ratio (D/E) of 470.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sirona Biochem Corp has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sirona Biochem until it has trouble settling it off, either with new capital or with free cash flow. So, Sirona Biochem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sirona Biochem Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sirona to invest in growth at high rates of return. When we think about Sirona Biochem's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 34.78 K. Net Loss for the year was (2.54 M) with profit before overhead, payroll, taxes, and interest of 621.75 K.
Sirona Biochem Corp has accumulated about 376.43 K in cash with (1.76 M) of positive cash flow from operations.

Sirona Biochem Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sirona Stock often depends not only on the future outlook of the current and potential Sirona Biochem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sirona Biochem's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding253.6 M

Sirona Biochem Technical Analysis

Sirona Biochem's future price can be derived by breaking down and analyzing its technical indicators over time. Sirona Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sirona Biochem Corp. In general, you should focus on analyzing Sirona Stock price patterns and their correlations with different microeconomic environments and drivers.

Sirona Biochem Predictive Forecast Models

Sirona Biochem's time-series forecasting models is one of many Sirona Biochem's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sirona Biochem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sirona Biochem Corp

Checking the ongoing alerts about Sirona Biochem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sirona Biochem Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sirona Biochem Corp is way too risky over 90 days horizon
Sirona Biochem Corp has some characteristics of a very speculative penny stock
Sirona Biochem Corp appears to be risky and price may revert if volatility continues
Sirona Biochem Corp has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Sirona Biochem Corp has accumulated 637.65 K in total debt with debt to equity ratio (D/E) of 470.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sirona Biochem Corp has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sirona Biochem until it has trouble settling it off, either with new capital or with free cash flow. So, Sirona Biochem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sirona Biochem Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sirona to invest in growth at high rates of return. When we think about Sirona Biochem's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 34.78 K. Net Loss for the year was (2.54 M) with profit before overhead, payroll, taxes, and interest of 621.75 K.
Sirona Biochem Corp has accumulated about 376.43 K in cash with (1.76 M) of positive cash flow from operations.

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.